Thank you for inviting us to the committee to discuss improvements to treatment for patients with Lyme disease and associated tick-borne diseases. Lyme disease is an infection that is passed to humans by the bite of a tick. It is caused by bacteria known as Borrelia. The best known species is Borrelia burgdorferi, but multiple species exist, of which at least five are prevalent in Scotland.
Typical initial symptoms of Lyme disease are a bull’s-eye rash and flu-like illness. More serious symptoms may develop weeks, months or even years later if the disease is left untreated. Later symptoms include joint pain and swelling, headaches, extreme fatigue and problems affecting the nervous system, heart and membranes surrounding the brain and spinal cord. If infection is caught early, most patients recover with standard treatment. However, 10 to 20 per cent of patients go on to develop a debilitating chronic illness.
On average, 5 per cent of ticks in Scotland are infected with Borrelia. In 1996 there were fewer than 30 laboratory-confirmed cases of tick-borne disease in Scottish patients, but by 2014 there were around 230 cases. However, the true number is likely to be much higher, because general practitioners estimate that only 20 to 40 per cent of cases are referred. Lyme disease is not notifiable, so nobody really knows. Tests on donated blood have concluded that 4.2 per cent of Scottish blood donors have positive Borrelia serology. That equates to 225,000 people having been infected, although not everyone who is infected has current symptoms. The prevalence of positive serology was even higher in the Highlands, with 8.6 per cent infection in the Inverness area.
Earlier this year, Alexander Burnett MSP—who is here today—lodged a Scottish Parliament motion on “Lyme disease: the need to do more”. In June, in the debate on the motion, Liam Kerr MSP stated that Lyme disease is expected to
“reach epidemic levels by 2028.”—Official Report, 14 June 2017; c 116.
There are numerous issues with testing and diagnosis. A patient may not remember a tick bite. Nymph ticks are the size of a poppy seed and are easily missed. There may not be a bull’s-eye rash—in the recent Scottish study, only 48 per cent of patients had such a rash. Testing is unreliable; in a recent analysis of test kits, it was found that Lyme disease generated more than 500 times more false negative results than HIV testing. In addition, immune response has been found to be undulatory, which means that test results can be negative during infection. There are no tests for two of the five species of infection that are found in Scotland, and ticks can transmit multiple infections from a single bite. Co-infections have been found to increase the length and severity of illness and there are no tests that cover all species of such co-infections. Given the unreliability of testing, it is very easy for Lyme disease and its related co-infections to be misdiagnosed.
10:30
There are also issues with treatment. There are a huge number of uncertainties in the treatment of Lyme disease. However, there have now been more than 700 peer-reviewed papers demonstrating the persistence of Borrelia after antibiotic treatment. Dr Berkowitz, a Lyme disease consultant who spoke at Holyrood in June, stated:
“there is now a mountain of good and indisputable scientific evidence that Lyme disease and its co-infections can become persistent and that various organisms have survival techniques to survive and even to thrive through courses of antibiotics.”
In fact, Borrelia has been found to be one of the most complex bacteria known to man.
The treatment of Lyme disease in Scotland has followed guidelines that were developed by the Infectious Diseases Society of America—IDSA—in 2006, before the recent medical understanding of the complexities and persistence of Borrelia. They have been removed from the US national guideline clearinghouse because they are now considered to be too out of date, and IDSA has not produced more recent guidelines.
In 2011, the British Infection Association issued a position paper that supported the IDSA point of view, stating that a diagnosis of chronic Lyme disease should not be made without “clinical or laboratory evidence.” Without reliable tests for Lyme disease and co-infections, there is no evidence to allow patients to get treated appropriately. Abandoned by the national health service in Scotland, many patients, including us, seek private treatment abroad.
What needs to be done? First, there should be improved testing. A test should be provided that does not rely on antibodies. A commercial Lyme antigen test that does not depend on the presence of antibodies and is described as
“a game changing tool for Lyme disease diagnosis”
is now available in Europe, but it is not yet available to Scottish patients. Also, more testing should be provided for all Borrelia species and co-infections.
Secondly, there should be improved treatment through the provision of better guidelines. Guidelines are needed that acknowledge the recent research showing that Lyme bacteria can persist through courses of antibiotics. The National Institute for Health and Care Excellence has been asked by NHS England to develop guidance on the diagnosis and management of Lyme disease, which is expected to be published next year. If the guidelines do not acknowledge persistence, we in Scotland should develop our own.
We should also establish a specialist treatment centre. We want a Scottish vector-borne illness treatment centre to be established to deal with complex cases that has a multidisciplinary team of specialists in infectious diseases, immunology, functional medicine and nutrition. In addition, the resources should be provided for research into and development of treatment of chronic tick-borne infections in Scotland.
Thirdly, education should be improved. Consultants, general practitioners and medical students should be taught to ensure that they are fully up to date on the persistence of Borrelia and co-infections and the complexity of treatment. The public must be taught to ensure that they understand the dangers and how to protect themselves. We want landowners to be required to display suitable warning notices at, for example, visitor centres and car parks.
We call on the medical and political leaders in Scotland to follow France’s example in ensuring that the recent acknowledgement of the complexities of Lyme disease is followed by a change of policy regarding treatment and that more resources are put into tackling the condition, which is increasing in prevalence and poses a great danger of negatively affecting the tourist industry and placing a burden on Scotland’s wider economy. If Lyme disease is going to reach epidemic levels by 2028, now is the time to act.